Correlation Between Inozyme Pharma and Treace Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Treace Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Treace Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Treace Medical Concepts, you can compare the effects of market volatilities on Inozyme Pharma and Treace Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Treace Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Treace Medical.

Diversification Opportunities for Inozyme Pharma and Treace Medical

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Inozyme and Treace is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Treace Medical Concepts in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Treace Medical Concepts and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Treace Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Treace Medical Concepts has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Treace Medical go up and down completely randomly.

Pair Corralation between Inozyme Pharma and Treace Medical

Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Treace Medical. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.51 times less risky than Treace Medical. The stock trades about -0.13 of its potential returns per unit of risk. The Treace Medical Concepts is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  1,262  in Treace Medical Concepts on November 7, 2024 and sell it today you would lose (221.50) from holding Treace Medical Concepts or give up 17.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.51%
ValuesDaily Returns

Inozyme Pharma  vs.  Treace Medical Concepts

 Performance 
       Timeline  
Inozyme Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inozyme Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Treace Medical Concepts 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Treace Medical Concepts are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental indicators, Treace Medical demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Inozyme Pharma and Treace Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inozyme Pharma and Treace Medical

The main advantage of trading using opposite Inozyme Pharma and Treace Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Treace Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Treace Medical will offset losses from the drop in Treace Medical's long position.
The idea behind Inozyme Pharma and Treace Medical Concepts pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Correlations
Find global opportunities by holding instruments from different markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
CEOs Directory
Screen CEOs from public companies around the world